What is BIIB stock price today?

BIIB (Biogen Inc) stock is trading at $191.95 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is BIIB stock going up or down today?

BIIB stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy BIIB stock now?

The decision to buy BIIB depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is BIIB a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for BIIB based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is BIIB stock overvalued or undervalued?

BIIB currently trades at a P/E ratio of 21.39 relative to earnings. Our DCF calculator provides intrinsic value estimates to help determine if BIIB is fairly priced.

What is BIIB's P/E ratio?

BIIB has a price-to-earnings (P/E) ratio of 21.39, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is BIIB's market cap?

BIIB (Biogen Inc) has a market capitalization of $29.33 billion, making it a mid-cap stock.

What is BIIB's price to book ratio?

BIIB trades at a price-to-book (P/B) ratio of 1.57, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does BIIB pay dividends?

BIIB does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is BIIB's dividend yield?

BIIB does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is BIIB stock a good long-term investment?

BIIB's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is BIIB's revenue growth rate?

Revenue growth data for BIIB is available on our dashboard with detailed financial statement analysis.

Profitability metrics for BIIB are available on our dashboard with complete income statement analysis.

What are the risks of investing in BIIB?

Key risks for BIIB include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does BIIB compare to its competitors?

Compare BIIB to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize BIIB's performance and positioning.

What is BIIB's stock price target for 2026?

Our AI model provides price targets for BIIB based on fundamental analysis: Bull case $249.53 (+30%), Base case $220.74 (+15%), Bear case $172.75 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about BIIB?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for BIIB. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is BIIB's next earnings report?

BIIB reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

BIIB - Biogen Inc

NYSE * Healthcare * Drug Manufacturers - General

$191.95

$-17.08 (-8.17%)

About Biogen Inc

Biogen Inc (BIIB) common stock

Price Chart

Loading chart...

BIIB Key Statistics

Market Cap

$29.33B

P/E Ratio

21.39

P/B Ratio

1.57

How BIIB Compares to Peers

BIIB is the smallest among peers, which may offer higher growth potential

P/E Rank

of 6

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
BIIB(This stock)	$29.33B	21.4	0%	0.0%	-
LLYEli Lilly	$991.62B	39.5	0%	0.0%	vs LLY
JNJJohnson &	$375.37B	17.4	0%	0.0%	vs JNJ
PFEPfizer Inc	$147.73B	19.8	0%	0.0%	vs PFE
MRKMerck &	$285.12B	32.5	0%	0.0%	vs MRK
ABBVAbbVie Inc	$334.34B	80.5	0%	0.0%	vs ABBV

Data Updated: July 14, 2026 at 9:24 PM EDT

Ready to invest in BIIB?

Commission-free trading available. Affiliate links.

BIIB Lician Score

14% confidence

4.0/10

Neutral

BIIB has a Lician Score of 4/10 (Average). Areas of concern: Growth, Quality.

value

5.0

growth

2.0

quality

2.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates BIIBacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

BIIB Financial Snowflake

5-axis analysis across key investment dimensions

3.8/10

Poor

5.0

Value

Valuation vs. sector peers

2.0

Growth

Revenue & earnings trajectory

2.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for BIIB

Dashboard

Enter a ticker to analyze